4//SEC Filing
Marken James G. 4
Accession 0001579587-23-000005
CIK 0001023024other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:17 PM ET
Size
11.7 KB
Accession
0001579587-23-000005
Insider Transaction Report
Form 4
Marken James G.
Vice President, Operations
Transactions
- Exercise/Conversion
Common Stock
2023-08-23$40.59/sh+3,750$152,213→ 135,377 total - Exercise/Conversion
Stock Option (right to buy)
2023-08-23$40.59/sh−3,750$152,213→ 0 totalExercise: $40.59Exp: 2026-04-06→ Common Stock (3,750 underlying) - Exercise/Conversion
Stock Option (right to buy)
2023-08-23$33.00/sh−1,667$55,011→ 0 totalExercise: $33.00Exp: 2024-03-31→ Common Stock (1,667 underlying) - Exercise/Conversion
Common Stock
2023-08-23$33.00/sh+1,667$55,011→ 137,044 total - Sale
Common Stock
2023-08-23$63.00/sh−3,932$247,716→ 133,112 total
Footnotes (2)
- [F1]25% of the total options vested on each of April 7, 2017, April 7, 2018, April 7, 2019, and April 7, 2020.
- [F2]25% of the total options vested on each of April 1, 2015, April 1, 2016, April 1, 2017, and April 1, 2018.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001579587
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 4:17 PM ET
- Size
- 11.7 KB